← Open Payments lookup

QUENTIN CHAMBERS: Open Payments

NPI 1750794319 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,623 in 104 payments from 12 companies in 2025. Trend: 2023 $1,044 · 2024 $1,639 · 2025 $2,623

Food & beverage: $2,619Education: $4
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.18$584
Alkermes, Inc.11$469
Vanda Pharmaceuticals Inc.12$395
E.R. Squibb & Sons, L.L.C.23$326
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$229
Teva Pharmaceuticals USA, Inc.11$202
Otsuka America Pharmaceutical, Inc.10$142
Takeda Pharmaceuticals U.S.A., Inc.5$105
ABBVIE INC.3$78
Supernus Pharmaceuticals, Inc.3$53

Products named: INGREZZA, FANAPT, COBENFY, LYBALVI, CAPLYTA, ARISTADA, REXULTI, AUSTEDO XR.

Industry payments across IA — which companies pay providers there.